{"id":164786,"date":"2025-01-20T15:25:59","date_gmt":"2025-01-20T14:25:59","guid":{"rendered":"https:\/\/stratec-med.com\/literatur\/spezielle-trainingstherapie-zur-reduktion-der-inflammation-bei-anti-jo-1-syndrom-special-training-therapy-to-reduce-inflammation-in-anti-jo-1-syndrome-2\/"},"modified":"2025-01-20T15:26:00","modified_gmt":"2025-01-20T14:26:00","slug":"spezielle-trainingstherapie-zur-reduktion-der-inflammation-bei-anti-jo-1-syndrom-special-training-therapy-to-reduce-inflammation-in-anti-jo-1-syndrome-2","status":"publish","type":"literatur","link":"https:\/\/stratec-med.com\/en\/literature\/spezielle-trainingstherapie-zur-reduktion-der-inflammation-bei-anti-jo-1-syndrom-special-training-therapy-to-reduce-inflammation-in-anti-jo-1-syndrome-2\/","title":{"rendered":"Spezielle Trainingstherapie zur Reduktion der Inflammation bei Anti-Jo-1-Syndrom (Special Training Therapy to Reduce Inflammation in Anti-Jo-1 Syndrome)"},"content":{"rendered":"<p>Zusammenfassung:<br \/>\nWir berichten \u00fcber den Fall eines 46-j\u00e4hrigen Patienten mit medikament\u00f6s behandeltem Anti-Jo-1-Syndrom. Aufgrund einer progressiven Verschlechterung der Lungenfunktion, Dyspnoe, Abgeschlagenheit und myositischen Beschwerden hatte der Patient bereits systemische Steroide und Azathioprin erhalten. Obwohl hohe Dosen von systemischen Steroiden und Azathioprin gegeben wurden, nahmen die muskuloskelettalen Symptome zu. Der Patient, der sonst regelm\u00e4\u00dfig Langstreckenl\u00e4ufe von 20km L\u00e4nge unternahm, konnte dieser Form der k\u00f6rperlichen Belastung nicht mehr nachgehen. Wir entschlossen uns, den Patienten mitHilfe desGalileoTM-Ger\u00e4tesmit einer regelm\u00e4\u00dfigen aktiven Muskeltherapie (ausgel\u00f6st durch Dehnreflexe) zu behandeln. Vor Beginn und nach drei Monaten regelm\u00e4\u00dfigen Trainings haben wir folgende Untersuchungen durchgef\u00fchrt Messung der Lebensqualit\u00e4t mittels St. Georges Respiratory Questionnaire (SGRQ), ultrasonografische Planimetrie des Musculus quadriceps, 6-Minuten-Gehtest, Lungenfunktionstest sowie die Messung der Serummarker der allgemein-systemischen<br \/>\nund muskelspezifischen Inflammation (TNF-alpha, Interleukin-8, CRP, CK, Myoglobin).<br \/>\nUnter dem Training mit dem GalileoTM-Ger\u00e4t in 5 Trainingseinheiten\/Woche kam es innerhalb von zwei Monaten zur deutlichen Besserung des Patienten. Wir f\u00fchren die Trainingstherapie fort.<\/p>\n<p>ABSTRACT:<br \/>\nA 46-year-old patient was frequently seen with a medically treated Anti-Jo-1syndrome. The patient had already been treated with azathioprine and oral corticosteroids on account of decreasing lung function, dyspnoea, fatigue, and beginning signs of myositis. Although high doses of steroids and azathioprine were administered, the muscleskeletal syndromes increased steadily. The patient used to be an active long-distance runner (20km), but now was unable to perform that kind of physical exercise. It was decided to start a treatment with the GalileoTM training device for active muscle training of the lower extremities.<br \/>\nBefore and after three months of training the following assessment was performed: measurement of health-related quality of life (St. Georges respiratory questionnaire, SGRQ), ultrasound measurement of the cross-sectional area of the quadriceps muscle, 6 minute walk test (6 MWT), lung function testing, and assessment of serum markers<br \/>\nof inflammation (TNF-alpha, interleukin-8, CRP, CK, myoglobin). After only two months,<br \/>\ntraining with the GalileoTM five times a week has improved the patient\u2019s conditions dramatically. The training will be continued.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: Wir berichten \u00fcber den Fall eines 46-j\u00e4hrigen Patienten mit medikament\u00f6s behandeltem Anti-Jo-1-Syndrom. Aufgrund einer progressiven Verschlechterung der Lungenfunktion, Dyspnoe,<\/p>\n","protected":false},"author":22,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false},"tags":[1569,966,1565,1567,1566,1568],"thema":[5876,5888,5878,5882,5890,5880,5856],"produktgruppe":[7527,5831,5829],"literatur_kategorie":[7221],"class_list":["post-164786","literatur","type-literatur","status-publish","format-standard","hentry","tag-grfs106","tag-ck","tag-copd-pneumologie","tag-il-8","tag-inflammatory-markers","tag-tnf-alpha","thema-diseases","thema-geriatrics","thema-medical-applications","thema-neurological-conditions","thema-paediatrics","thema-pyhsitherapy-rehabilitation","thema-therapy-prevention-using-galileo","produktgruppe-galileo-en","produktgruppe-galileo-therapy","produktgruppe-galileo-training-en","literatur_kategorie-clinical-studies"],"acf":[],"_links":{"self":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur\/164786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur"}],"about":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/types\/literatur"}],"author":[{"embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/users\/22"}],"version-history":[{"count":0,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur\/164786\/revisions"}],"wp:attachment":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/media?parent=164786"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/tags?post=164786"},{"taxonomy":"thema","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/thema?post=164786"},{"taxonomy":"produktgruppe","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/produktgruppe?post=164786"},{"taxonomy":"literatur_kategorie","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur_kategorie?post=164786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}